60 mins. ago
HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into a record 48% margin. Management raised full-year revenue and profit guidance on the back of that performance, and the numbers suggest a business getting more efficient even as it gets bigger.
The account growth alone would make for a solid quarter. New HSAs from sales rose 24% year over year to 202,000, the strongest second quarter the company has posted and its best stretch outside the fourth quarter open enrollment window. Total HSA ***** ets reached $37.9 billion, up 14%, while HSA invested ***** ets climbed 28% to $20.6 billion as 939,000 accounts now hold investments, a 20% increase. That distinction matters because members who invest carry balances four times larger than those who do not, so every account that starts investing compounds the relationship's value without HealthEquity signing up a single new client.
Engagement is following the same curve. Monthly active users on the mobile app hit 1.4 million in July, up 62% year over year, and total downloads passed 5 million. Marketplace, still a small piece of the business with about 14,000 active members, is already showing that purchasers are more likely to start contributing to their HSA than members who never buy anything through it. AI-driven automation resolved 85% of routine chat inquiries and contained 55% of card-related phone contacts, helping cut human-handled service calls by 25% even as total accounts grew 4%. Gross margin expanded to 74% of revenue from 71% a year earlier, and the company returned $108.1 million to shareholders through buybacks during the quarter.
Not everything is friction-free. CFO James Lucania acknowledged the competitive pressure on pricing, telling ***** ysts there is "absolutely headline price erosion," a year-over-year reduction that weighs on service revenue even as that segment still grew 6% to $124.4 million. GAAP net income of $65.6 million, or $0.78 per diluted share, ran well below the $103.8 million and $1.24 per share reported on a non-GAAP basis, a gap that included $3.3 million in one-time disposal costs tied to internally developed software the company no longer uses.
#year #million #members #healthequity
The account growth alone would make for a solid quarter. New HSAs from sales rose 24% year over year to 202,000, the strongest second quarter the company has posted and its best stretch outside the fourth quarter open enrollment window. Total HSA ***** ets reached $37.9 billion, up 14%, while HSA invested ***** ets climbed 28% to $20.6 billion as 939,000 accounts now hold investments, a 20% increase. That distinction matters because members who invest carry balances four times larger than those who do not, so every account that starts investing compounds the relationship's value without HealthEquity signing up a single new client.
Engagement is following the same curve. Monthly active users on the mobile app hit 1.4 million in July, up 62% year over year, and total downloads passed 5 million. Marketplace, still a small piece of the business with about 14,000 active members, is already showing that purchasers are more likely to start contributing to their HSA than members who never buy anything through it. AI-driven automation resolved 85% of routine chat inquiries and contained 55% of card-related phone contacts, helping cut human-handled service calls by 25% even as total accounts grew 4%. Gross margin expanded to 74% of revenue from 71% a year earlier, and the company returned $108.1 million to shareholders through buybacks during the quarter.
Not everything is friction-free. CFO James Lucania acknowledged the competitive pressure on pricing, telling ***** ysts there is "absolutely headline price erosion," a year-over-year reduction that weighs on service revenue even as that segment still grew 6% to $124.4 million. GAAP net income of $65.6 million, or $0.78 per diluted share, ran well below the $103.8 million and $1.24 per share reported on a non-GAAP basis, a gap that included $3.3 million in one-time disposal costs tied to internally developed software the company no longer uses.
#year #million #members #healthequity
